LXRX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

LXRXLexicon Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

LXRXLexicon Pharmaceuticals, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LXRX2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26±25.8%▲+8.78%×0.34

Q2 FY26±22.0%▼−3.67%×0.17

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedLXRX realized, solidLLY realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedspan: LXRX 91d · LLY 267dSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

LXRXLexicon Pharmaceuticals, Inc.

1.81▲+12.45%

Mkt cap$716.8MRevenue$11MQ3 FY26Revenue$144MFY25

LLYELI Lilly & Co

1,369.55▲+0.35%

Regular sessionNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 6 '26

LXRXLexicon Pharmaceuticals, Inc.

LLYELI Lilly & Co

1.81▲+12.45%

Price

1,369.55▲+0.35%

$716.8M

Mkt cap

$1.2T

Q3 FY26$11M

Revenue

$24.4BQ3 FY26

FY25$144M

Revenue

$65.2BFY25

LXRX1.81▲+12.45%vsLLY1,369.55▲+0.35%Regular sessionNov 6 '26